|
A
Personal Account of receiving RA Treatment
This
account was sent to ra-petition.org.uk and it is reproduced here
in the hope that it might better inform our visitors of the process
of receiving treatment. If you would like to add your accounts
please email info@ra-petition.org.uk
When
my local Arthritis Clinic began its biological treatment in the
Summer of 2002, patients were separated into those destined for
the anti-TNF therapy and those who had to remain on conventional
disease modifying drugs. To clarify "biological " in this context,
the drugs used are derivatives of protein based treatments.
Firstly,
patients
had to undergo an assessment, in which the following were taken
into consideration:
1)
The general state of inflammation
- measured
by the doctors by feeling the joints
- based on
recent blood tests
- patients
pain assessment on a scale from 1 to 10 where the cut off point
was five. Any pain factor above 5 could be taken into consideration.
2) the general
state of health
- patients
had to have a blood test
- patients
had to have a lung x-ray
- patients
had to have a test for Tuberculosis - i.e. the absence of
3)
if all tests proved satisfactorily, they were admitted to the
treatment programme.
Those
receiving ENBREL were shown how to inject themselves with the
drug on a twice weekly dosage; similar to diabetics who also have
to give themselves Insulin injections.
Those
receiving INFLIXIMAB on the other hand undergo an infusion treatment.
Patients also have to take at least one of their disease modifying
drugs, mostly methotrexate. In my case I had to stay with Leflunomide
though on a reduced dosage. Infliximab as an anti-inflammatory
treatment was first used in Crohns Disease, and therefore has
a proven tract record, but the treatment it not cheap. Around
£12,000 per year per person. I understand that the cost of ENBREL
has also gone up and is now around £10,000 a year per person.
The INFLIXIMAB infusion is prepared on the day of the patient's
arrival, the powder form is measured out based on the patients
weight. At first the patient will be given a saline solution,
then the infusion solution and finally another saline solution
to flush the Infliximab through. There are certain rules how fast
the drip can run, and it is constantly monitored to adjust the
flow.
A new patient will be given the infusion at shorter intervals
than normal: with a two weekly interval after the first treatment,
then a four week interval and finally an eight week interval.
After that the interval remains at eight weeks.
During the session the patients blood pressure is continuously
measured, and at least one doctor comes to listen to the patients'
heart rate. Patients will also be asked questions and may or may
not have their joints examined.
I
have talked with people, who had RA for 20 years or more, who
could only walk on two crutches and who are now walking normally
and unaided. On a personal account, my RA started four years ago
and did not respond well to any of the conventional treatments.
It was deemed an aggressive form. After years of trauma when the
drug treatments failed, I started in September 2002 on the infusion
treatment and my RA has been in recession since last spring. I
cannot thank my local Arthritis Clinic enough and also my local
Health Authority for all they have done for me. I believe that
while there is no cure for RA, everybody should have at least
the chance to take part in the biological treatments. For that
reason, it is necessary to collect more and more signatures to
persuade those with the purse strings, that people with RA deserve
a better quality of life and be able to live pain free lives.
|